"Sapphire were very professional and understood all the difficulties of doing an EIS application for a company based in the Netherlands. They held our hand throughout the entire process and provided a first class service." Richard Irwin, Genalice B.V.
Description:
GENALICE is a Netherlands based company. Acting for Genalice, Sapphire assisted the company to obtain advance assurance for the Enterprise Investment Scheme.
GENALICE is a highly innovative biomedical big data company. GENALICE designs and builds groundbreaking software solutions for highly accurate, ultra-fast, and cost-effective Next-Generation Sequencing (NGS) data processing and analysis.
GENALICE MAP can process a whole human genome from FASTQ to VCF in 30 minutes and performs population calling in less than 6 minutes per sample on a single node. MAP is the only product on the market, which addresses all challenges of high volume NGS data processing: accuracy, speed, efficient storage, and ease of use for research and clinical application.
